Skip to main content

Bell Investment Advisors, Inc

Position in DNLI — Denali Therapeutics Inc.

CIK 1890149 ORINDA, CA

Position in DNLI

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$977
+$248 QoQ
Shares Held
38
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#267
of 290 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bell Investment Advisors, Inc holds $389,495 across 65 Biotechnology names. DNLI ranks #38 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $977 38
2026-03-31 $729 38
2025-12-31 $627 38
2025-09-30 $856 59
2025-06-30 $1,720 123
2025-03-31 $706 52
2024-12-31 $1,059 52
2024-09-30 $1,514 52
2024-06-30 $1,207 52
2024-03-31 $1,067 52
2023-12-31 $1,652 77
2023-09-30 $887 43
2023-06-30 $1,888 64
2023-03-31 $1,474 64
2022-12-31 $1,779 64
2022-09-30 $1,964 64
2022-06-30 $1,883 64
2021-12-31 $490 11
2021-09-30 $1,210 24